Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP908328.RAAbobLdo33nBD4V6dvZjnuixd1XKUutGax0hOoxniGFo130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP908328.RAAbobLdo33nBD4V6dvZjnuixd1XKUutGax0hOoxniGFo130_provenance.
• NP532876.RAAx6IL4ewPC2LkWANCM2z0rSXl12dgparOgUY3EHEE2g130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP532876.RAAx6IL4ewPC2LkWANCM2z0rSXl12dgparOgUY3EHEE2g130_provenance.
• NP562846.RApnDKT6ZAo5e_jFm6ghjvVrEVc4YQWImBTXfoU0QJM_o130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562846.RApnDKT6ZAo5e_jFm6ghjvVrEVc4YQWImBTXfoU0QJM_o130_provenance.
• NP796423.RAaZJJl0NXwom0G8M9zliR9c6Q9sGGrB6Sk5bCHzrRwMo130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP796423.RAaZJJl0NXwom0G8M9zliR9c6Q9sGGrB6Sk5bCHzrRwMo130_provenance.
• NP438407.RAQuLEc1bzDqR6JEUyMSOIfTEjLB8eWVq2JHuIOcCyujw130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438407.RAQuLEc1bzDqR6JEUyMSOIfTEjLB8eWVq2JHuIOcCyujw130_provenance.
• assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP516099.RARRwqMXvZ2njHn_OzQlskZZWTXbHFhA7dOx4gre7O6gs130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516099.RARRwqMXvZ2njHn_OzQlskZZWTXbHFhA7dOx4gre7O6gs130_provenance.
• NP662296.RA6w5FSYDZYku7ZEZryuogtpIFJ6bMwN_yQBGpJhHDDRk130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662296.RA6w5FSYDZYku7ZEZryuogtpIFJ6bMwN_yQBGpJhHDDRk130_provenance.
• NP493847.RAb-cUiqY5HLLfxD18zKUGX0FORHpVzP6_j24AdJPzm4w130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493847.RAb-cUiqY5HLLfxD18zKUGX0FORHpVzP6_j24AdJPzm4w130_provenance.
• assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP823633.RAHyCG75jkfAbIK1rUVUUZ5oAb0-arPktDaCkK3tikO-E130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823633.RAHyCG75jkfAbIK1rUVUUZ5oAb0-arPktDaCkK3tikO-E130_provenance.
• NP553424.RAcIUsNhcUUHGf8EDbURRXnz3jOnCma75eH0DpzLcWGGA130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553424.RAcIUsNhcUUHGf8EDbURRXnz3jOnCma75eH0DpzLcWGGA130_provenance.
• NP553425.RAQMXP3fjPdOrlq1YQ66jCnyFov-gX6LzT4y8ryW-5V-c130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553425.RAQMXP3fjPdOrlq1YQ66jCnyFov-gX6LzT4y8ryW-5V-c130_provenance.
• NP331186.RAt-gFQSXSj-SkZTS3Jj3L7LhvXz0-9vJNsBOgqyprh-Y130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331186.RAt-gFQSXSj-SkZTS3Jj3L7LhvXz0-9vJNsBOgqyprh-Y130_provenance.
• NP553423.RAml5FP4G0nb9NvZALeg9gxQuXsRIHbhjf5quqdpFDI4U130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553423.RAml5FP4G0nb9NvZALeg9gxQuXsRIHbhjf5quqdpFDI4U130_provenance.
• NP493373.RA2ItgzVcCxEyYF4OgZFzHQftwQmzgTY46DZuPAvN25QM130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493373.RA2ItgzVcCxEyYF4OgZFzHQftwQmzgTY46DZuPAvN25QM130_provenance.
• NP515698.RAGTXA7zlxM1R5xZ_JX4CAsidwIOmeRzJGF6-W5gr4Lm0130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515698.RAGTXA7zlxM1R5xZ_JX4CAsidwIOmeRzJGF6-W5gr4Lm0130_provenance.
• NP330103.RAFeUjPiQOWeOGskv2xt-bixMqMVAhafvPSSBW_5ADjCM130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330103.RAFeUjPiQOWeOGskv2xt-bixMqMVAhafvPSSBW_5ADjCM130_provenance.
• NP553426.RAKFnlt-nYNRIythg0PxOT7CDOWzW5iWntgqDB-2Gb5pY130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553426.RAKFnlt-nYNRIythg0PxOT7CDOWzW5iWntgqDB-2Gb5pY130_provenance.
• NP553428.RAGm6xZj3nM7gstvLF2uBS8cYoRPLYwqbbFCFv6_nU7aY130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553428.RAGm6xZj3nM7gstvLF2uBS8cYoRPLYwqbbFCFv6_nU7aY130_provenance.
• NP553427.RAy97lt_xBfWDphpMD8liRKkhwSXXS1Wr-hRSO42uz-1c130_assertion description "[Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553427.RAy97lt_xBfWDphpMD8liRKkhwSXXS1Wr-hRSO42uz-1c130_provenance.